Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | CTSA | P10619 | 1/20 | 0.35 |
| ▸ | CD38 | P28907 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4949819 | 0.81 | CTSA (0.38) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL3672732 | 0.77 | KDM4E (0.40) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL2306128 | 0.75 | SYK (0.48) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL1937751 | 0.74 | PARP1 (0.53) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL497429 | 0.74 | PARP1 (0.53) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL5196284 | 0.74 | PARP1 (0.53) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL31659783 | 0.74 | CYP17A1 (0.47) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL6378764 | 0.74 | ADRA1D (0.47) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL31659786 | 0.74 | ADRA1D (0.47) | PARP1SYKKDM4EALDH1A1HPGD | |
| SCHEMBL19028143 | 0.74 | CYP17A1 (0.47) | PARP1SYKKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270190-A1 | KIT INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2025-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270190-A1 | KIT INHIBITORS | KIT, ABL1, APC | PARP1 2111/4885SYK 762/4885KDM4E 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.